UBS Group’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,700
Closed -$40K 10313
2021
Q4
$40K Sell
1,700
-10,400
-86% -$241K ﹤0.01% 7111
2021
Q3
$265K Buy
+12,100
New +$294K ﹤0.01% 5118

Other funds holding CLVT

UBS Group's CLVT Position: Q2 2026 in Review

UBS Group reduced its Clarivate (CLVT) stake by 37% in Q2 2026, selling an estimated $8.1M and leaving 5,536,541 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #3258.

UBS Group first reported a position in CLVT in Q4 2018 and has held it in 30 quarters since. The position peaked at $45.9M in Q4 2022. 242 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • UBS Group held 5,536,541 shares of Clarivate worth $12M as of Q2 2026.
  • UBS Group sold 3,312,542 Clarivate shares in Q2 2026, an estimated $8.1M.
  • Clarivate made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3258 holding.
  • UBS Group first reported a position in Clarivate in Q4 2018 and has held it in 30 quarters since.
  • UBS Group's Clarivate position peaked at $45.9M in Q4 2022.
  • 242 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.